Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated

26.85
BRL
+1.68
(+6.67%)
-0.32EPS
35.63BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.87
0.93
0.94
0.9
0.86
0.87
0.88
0.89
0.89
0.88
0.85
0.83
0.8
0.78
Basic EPS, GAAP
0.02
0.08
0.17
0.19
0.05
0.14
0.07
0.13
0.11
0.04
-0.18
-0.44
-0.17
-0.06
Free Cash Flow per Basic Share
0.13
0.14
0.26
0.18
0.2
0.27
0.28
0.68
0.22
0.11
0.17
0.17
0.09
0.09
Dividend per Share
0.3
0.3
0.29
0.29
0.29
0.3
0.29
0.29
0.3
1.36
0.3
0.3
0.27
0.23
Book Value per Share
3.15
3
2.97
3.45
3.48
3.33
3.43
3.39
3.53
4.83
4.35
3.63
3.19
2.99
Tangible Book Value per Share
3.1
2.95
2.92
3.4
3.43
3.29
3.41
3.38
3.51
4.64
4.15
3.61
3.18
2.99
Basic Weighted Avg Shares
374
392
408
447
485
507
527
551
587
1,038
1,559
1,504
1,439
1,430
Sales/Revenue/Turnover
325
365
383
402
417
442
462
492
525
919
1,326
1,249
1,152
1,117
Operating Margin (%)
27.01
28.42
27.89
26.46
22.07
18.35
16.79
16.65
16.33
9.01
4.09
2.93
8.24
11.83
Depreciation Expense
105
116
120
131
146
167
181
195
207
478
776
722
611
569
Net Income, GAAP
7
32
69
86
23
70
39
72
67
41
-278
-654
-246
-87
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
2.14
8.73
18.11
21.28
5.54
15.77
8.48
14.67
12.71
4.45
-20.98
-52.39
-21.35
-7.78
Working Capital
-68
-19
-144
9
-81
-180
-243
82
-185
-189
-57
302
260
-335
LT Debt
1,110
1,319
1,225
1,157
1,095
1,084
1,231
1,714
1,710
5,356
4,949
4,960
4,027
4,127
Total Equity
1,245
1,221
1,243
1,653
1,790
1,717
1,900
1,948
2,185
7,682
6,923
5,306
4,677
4,273
Return on Invested Capital (%)
- -
3.98
2.54
3.64
1.31
2.62
2.17
1.63
1.66
-0.92
- -
- -
- -
- -
Return on Capital (%)
- -
3.87
4.97
5.01
2.57
4
2.94
3.62
3.08
2.16
- -
- -
- -
- -
Return on Common Equity (%)
0.59
2.59
5.64
5.91
1.34
3.98
2.17
3.75
3.23
0.84
-3.87
-10.86
-5
-1.92

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
120
306
276
LT Borrowings
3,791
3,798
3,891
LT Finance Leases
236
236
236
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,447
1,426
1,410
Market Capitalization
6,182
6,413
6,893

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
606
150
115
Cash, Cash Equivalents & STI
26
26
19
Accounts Receivable, Net
170
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
346
458
450
Payables & Accruals
211
138
160
ST Debt
120
306
276
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.9%
43.72%
-11.86%
Free Cash Flow
20.83%
1.65%
-49.75%
Net Income, GAAP
-56.11%
-150.78%
-62.4%
Sales/Revenue/Turnover
13.81%
22.5%
-7.75%
Total Cash Common Dividend
65.63%
125.02%
-15.49%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
327
316
315
291
1,249
2025
299
298
298
258
1,152
2026
279
282
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.2
-0.09
-0.06
-0.07
-0.44
2025
-0.03
-0.11
-0.04
0.01
-0.17
2026
- -
-0.03
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.08
0.08
0.08
0.08
0.3
2025
0.08
0.08
0.06
0.06
0.27
2026
0.06
0.06
- -
- -
- -

Company Description

CEO
Peter A. Scott
Full Time Employees
539
Sector
Finance
Industry
Real estate investment trusts
Address
3310 West End Avenue Nashville TN United States 37203
IPO Date
Jun 6, 2012
Business
Healthcare Realty Trust Incorporated (NYSE: HR), a real estate investment trust founded in 1992 and headquartered in Nashville, Tennessee, owns, manages, acquires, develops and redevelops medical outpatient buildings primarily affiliated with market-leading health systems across 28 states in the United States. The company operates 579 properties totaling 33.6 million square feet as of September 30, 2025, offering integrated services including leasing and property management of high-quality on-campus and adjacent facilities that support outpatient services such as surgery, cancer treatment, imaging and physician practices; it generates all revenue from these healthcare-related real estate assets leased to hospitals, health systems and medical groups. In recent developments, Healthcare Realty pursues aggressive portfolio optimization through asset sales and joint ventures, including expansion of its KKR partnership approaching $500 million in value with new contributions in 2024 and continued monetization of non-core parcels in 2025; the company advances a strategic plan emphasizing margin expansion, occupancy gains to 91.1% in same-store properties during Q3 2025, accelerated redevelopment spending, leadership transitions with a new president and CEO, and balance sheet strengthening via liquidity of about $1.2 billion and reduced leverage.

Company News

  • Here Are Tuesday’s Top Wall Street Analyst Research Calls: Akamai Technolgies, Apple, Blackrock, Ford Motor, Healthcare Realty Trust, Noble, Sunoco LP, Venture Global, Western Midstream Partners, Zoetis, and More

  • Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

  • Healthcare Realty Trust Releases Eighth Corporate Responsibility Report

  • Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call

  • Pensionfund PDN Acquires 59,719 Shares of Healthcare Realty Trust Incorporated $HR

  • Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR

  • State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR

  • Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)

  • PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplast

  • ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTIN

  • Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu

  • Healthcare Realty Trust (HR) Upgraded to Buy: What Does It Mean for the Stock?

  • ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

  • Bears are Losing Control Over Healthcare Realty Trust (HR), Here's Why It's a 'Buy' Now

  • After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)

  • Healthcare Realty Trust Q2 Earnings Call Highlights

  • Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript

  • Healthcare Realty Trust (HR) Q2 FFO and Revenues Beat Estimates

  • Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance

  • Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call